These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31766536)

  • 1. Serum Steroid Profiling by Liquid Chromatography-Tandem Mass Spectrometry for the Rapid Confirmation and Early Treatment of Congenital Adrenal Hyperplasia: A Neonatal Case Report.
    Cicalini I; Tumini S; Guidone PI; Pieragostino D; Zucchelli M; Franchi S; Lisi G; Lelli Chiesa P; Stuppia L; Laurenzi V; Rossi C
    Metabolites; 2019 Nov; 9(12):. PubMed ID: 31766536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
    Travers S; Martinerie L; Bouvattier C; Boileau P; Lombès M; Pussard E
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):202-211. PubMed ID: 27339652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia.
    Fiet J; Le Bouc Y; Guéchot J; Hélin N; Maubert MA; Farabos D; Lamazière A
    J Endocr Soc; 2017 Mar; 1(3):186-201. PubMed ID: 29264476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
    Pussard E; Travers S; Bouvattier C; Xue QY; Cosson C; Viengchareun S; Martinerie L; Lombès M
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105553. PubMed ID: 31778802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry.
    Rossi C; Calton L; Hammond G; Brown HA; Wallace AM; Sacchetta P; Morris M
    Clin Chim Acta; 2010 Feb; 411(3-4):222-8. PubMed ID: 19931522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.
    de Hora MR; Heather NL; Patel T; Bresnahan LG; Webster D; Hofman PL
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):904-912. PubMed ID: 33471388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
    Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
    Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal screening for congenital adrenal hyperplasia.
    White PC
    Nat Rev Endocrinol; 2009 Sep; 5(9):490-8. PubMed ID: 19690561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wisconsin's Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia.
    Bialk ER; Lasarev MR; Held PK
    Int J Neonatal Screen; 2019 Sep; 5(3):33. PubMed ID: 33072992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
    Lacey JM; Minutti CZ; Magera MJ; Tauscher AL; Casetta B; McCann M; Lymp J; Hahn SH; Rinaldo P; Matern D
    Clin Chem; 2004 Mar; 50(3):621-5. PubMed ID: 14656905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
    Janzen N; Sander S; Terhardt M; Steuerwald U; Peter M; Das AM; Sander J
    Steroids; 2011 Dec; 76(13):1437-42. PubMed ID: 21839763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum steroid profile captures metabolic phenotypes in adults with classic congenital adrenal hyperplasia.
    Ahn CH; Shim J; Jang HN; Lee YA; Lee SW; Choi MH; Kim JH
    J Steroid Biochem Mol Biol; 2023 Nov; 234():106374. PubMed ID: 37572762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective LC-MRM/SIM-MS based profiling of adrenal steroids reveals metabolic signatures of 17α-hydroxylase deficiency.
    Lee C; Kim JH; Moon SJ; Shim J; Kim HI; Choi MH
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105615. PubMed ID: 32014605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
    Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand.
    de Hora MR; Heather NL; Webster DR; Albert BB; Hofman PL
    Int J Neonatal Screen; 2022 Oct; 8(4):. PubMed ID: 36278626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.